Revenio Group company profile
Company profile
Revenio Group has 765 employees and is headquartered in Vantaa, Finland.
The iCare tonometer range, including the iCare HOME2 for measuring eye pressure at home and the TONOVET models used in surgical settings and by veterinarians, forms the core of the product line of Revenio Group Oyj. Alongside these devices the company sells imaging equipment such as iCare EIDON and iCare COMPASS, and software including iCare ILLUME, which uses artificial intelligence to screen for early signs of eye disease, iCare CLINIC for long-term pressure records, and the Oculo platform for telehealth and remote patient monitoring. Its customers include ophthalmologists, veterinarians and other clinical staff, and it sells in Finland, the United States and other countries.
In the fiscal year ended December 2025, Revenio Group Oyj reported revenue of EUR 109.8 million, up 5.8% from the previous year, and net income of EUR 17.4 million. Founded in 2001, the company had 765 employees and is headquartered in Vantaa, Finland.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Finland
- Headquarters
- Härkähaankuja 7, 01730, Vantaa
- Employees
- 765
- Chief executive
- Jouni Toijala
- Founded
- 2001
- Fiscal year
- January - December
- Listing
- REG1V · Nasdaq Helsinki
- Currency
- EUR
- ISIN
- FI0009010912
- Website
- reveniogroup.fi
Revenio Group and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Revenio GroupREG1V | Finland | $428.87M | 765 | 14.1% | 25.1 |
| Synektik Spólka AkcyjnaSNT | Poland | $647.15M | 231 | 23.3% | 15.9 |
| El.En.ELN | Italy | $1.44B | 1,459 | 14.7% | 20.7 |
| ChemoMetecCHEMM | Denmark | $1.75B | 174 | 49.1% | 59.9 |
| ElektaEKTA.B | Sweden | $2.27B | 3,996 | 9.2% | — |
| Medacta GroupMOVE | Switzerland | $2.41B | 2,273 | 15.2% | 27.7 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
